Sphera Funds Management’s Aerie Pharmaceuticals AERI Stock Holding History

Sphera Funds Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150,000	Closed	-$7.13M	–	118
2019 Q1	$7.13M	Buy	+150,000	New	+$6.6M	0.65%	32
2015 Q2	–	Sell	-90,000	Closed	-$2.82M	–	164
2015 Q1	$2.82M	Buy	90,000 +1,484	+2%	+$43K	0.29%	85
2014 Q4	$2.58M	Sell	88,516 -75,000	-46%	-$1.9M	0.44%	77
2014 Q3	$3.38M	Buy	163,516 +53,516	+49%	+$1.06M	0.42%	56
2014 Q2	$2.73M	Sell	110,000 -2,500	-2%	-$43.3K	0.67%	37
2014 Q1	$2.38M	Buy	112,500 +2,500	+2%	+$50.5K	0.54%	39
2013 Q4	$1.98M	Buy	+110,000	New	+$1.43M	0.55%	48

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Sphera Funds Management's AERI Position: Q2 2019 in Review

Sphera Funds Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2019, closing a stake of 150,000 shares — an estimated $7.13M sold.

Sphera Funds Management first reported a position in AERI in Q4 2013 and held it in 7 quarters. The position peaked at $7.13M in Q1 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q2 2019.

Sphera Funds Management reported no remaining Aerie Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Sphera Funds Management sold 150,000 Aerie Pharmaceuticals shares in Q2 2019, an estimated $7.13M.
Sphera Funds Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 7 quarters.
Sphera Funds Management's Aerie Pharmaceuticals position peaked at $7.13M in Q1 2019.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.